Common Side Effects The most common adverse events reported in clinical trials include: Nausea: Reported by approximately 40% of participants, typically mild to moderate, related to melanocortin receptor activation in brainstem areas Flushing: Facial redness occurring in about 20% of users Injection site reactions: Pain, erythema, or bruising common with subcutaneous administration Headache: Affecting approximately 11% of participants These events are generally transient, occurring soon after administration and resolving within hours without intervention
Common Side Effects: These are temporary and usually resolve within a few days: Swelling at the injection site Redness or slight bruising Tenderness or soreness for 13 days Mild itching or sensitivity Lumps under the skin , which typically settle on their own Less Common Risks: Though rare, some people may experience: Prolonged swelling or hard nodules Asymmetry or uneven fat loss Infection (if not performed in a sterile setting) Skin irritation or allergic reaction to ingredients How to Minimize Side Effects: Choose a qualified, experienced medical professional avoid salons or uncertified clinics
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics
Powders offer the most flavor variety but require mixing and can be messier in the field
Binding metal ions (metal-binding proteins) and metal chelating
Xiao, L
